Schonfeld Strategic Advisors LLC Longeveron Inc. Transaction History

Schonfeld Strategic Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.25 - $2.51 $375 - $752	-300 Reduced 2.34%	12,500 $17,000
Q2 2023 Aug 14, 2023	BUY	$2.52 - $4.0 $504 - $800	200 Added 1.59%	12,800 $43,000
Q1 2023 May 15, 2023	BUY	$2.66 - $4.36 $532 - $872	200 Added 1.61%	12,600 $33,000
Q4 2022 Feb 14, 2023	SELL	$2.81 - $39.7 $1,405 - $19,850	-500 Reduced 3.88%	12,400 $39,000
Q3 2022 Nov 14, 2022	SELL	$3.97 - $42.7 $4,764 - $51,240	-1,200 Reduced 8.51%	12,900 $48,000
Q2 2022 Aug 15, 2022	SELL	$5.93 - $15.61 $1.03 Million - $2.72 Million	-174,310 Reduced 92.52%	14,100 $83,000
Q1 2022 May 16, 2022	BUY	$5.06 - $13.8 $953,354 - $2.6 Million	188,410 New	188,410 $2.6 Million

1.18K

Ticker LGVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,925,940
Market Cap $10.7M
Description
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult ...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.